ExamFinch.com My Study

Study guide

Interventional Fluoroscopy Dose Management & NCRP Report 168

Practice this exam

ABMP Medical Health Physics Exam

Track your progress as you read

Finished sections get a check mark.

1 Radiation Detection Instrumentation

Ionization Chambers & Geiger-Mueller Counters Scintillation Detectors, Photomultipliers & Gamma Spectroscopy Liquid Scintillation & Gamma Counting Systems: Well Counters & Thyroid Probes Personnel Dosimeters & Electronic Radiation Monitors Neutron Detection & Emergency Field Instrumentation

2 Laboratory Design & Contamination Control

Radiopharmaceutical Laboratory Design & USP <825> Standards Ventilation Systems, Fume Hoods & Contamination Engineering

3 Radiation Protection Standards & Dose Limits

Federal Regulatory Framework & Advisory Authorities Federal Guidance Documents: NRC Regulatory Guides, NUREGs, EPA & FDA Guidance Occupational & Public Dose Limits and ALARA Principles Radiobiological Basis of Limits & Risk Communication

4 Medical Licensing, Written Directives & Security

NRC Form 313 Authorizations, RSO Responsibilities & Written Directives Medical Event Reporting & 10 CFR 37 Category 1/2 Source Security

5 Diagnostic Radiology Structural Shielding

Diagnostic Shielding Methodology: NCRP Report 147 Modality Shielding: Radiography, Fluoroscopy & CT Facilities

6 Megavoltage Therapy Vault & Facility Shielding

Megavoltage Vault Primary & Secondary Barriers: NCRP Report 151 Therapy Maze Design, Photoneutrons & Shielded Doors PET/CT & Nuclear Medicine Facility Shielding (AAPM TG-108)

7 Radiation Oncology Quality Management & Safety

External Beam QA & Dosimetry Calibration Protocols Brachytherapy Safety, Inventory Control & Leak Testing

8 Radiation Oncology Emergency Procedures & TPS QA

Treatment Planning System (TPS) QA & Patient Verification Radiation Oncology Emergency Procedures: HDR Stuck Sources & Linac Failures Medical Events, Incident Investigation & Joint Commission Requirements in Radiation Oncology

9 Diagnostic Imaging Safety & Fluoroscopy Management

Diagnostic X-ray & Fluoroscopy Safety Interventional Fluoroscopy Dose Management & NCRP Report 168

10 CT Optimization, MQSA & Diagnostic Accreditation

Computed Tomography Dosimetry & Protocol Optimization Mammography Quality Standards Act (MQSA) & Mammography Physics Diagnostic Imaging Quality Management, Accreditation & Regulatory Oversight

11 Nuclear Medicine Radiopharmacy & Unsealed Therapy

Radiopharmaceutical QC & Radionuclide Calibrators Unsealed Source Therapy: I-131 Protocols & Patient Release Criteria

12 Targeted Radionuclide Therapy, Decontamination & RAM Transport

Targeted Radionuclide Therapies: Lu-177, Ra-223, Y-90 & Radioimmunotherapy Contamination Surveys, Spill Response & Personnel Decontamination Radioactive Waste Disposal & US DOT Transport Regulations

13 Radiobiology & Radiation Risk Assessment

Cellular Radiobiology, DNA Damage & Dose-Response Models Prenatal Radiation Risks & Population Exposures

14 Non-Ionizing Radiation Safety: Lasers & MRI

Healthcare Laser Safety: ANSI Z136.1 & Z136.3 MRI Safety, Facility Design & Bioeffects

Interventional Fluoroscopy Dose Management & NCRP Report 168

Key Takeaways Explain This Topic AI

Skin injuries are tissue reactions with thresholds: transient erythema about 2 Gy (hours), temporary epilation about 3 Gy (about 3 weeks), main erythema about 6 Gy, permanent epilation about 7 Gy, and dry and moist desquamation about 14 and 18 Gy (about 4 weeks), per ICRP 85.

Peak skin dose is estimated from reference air kerma by correcting for the actual skin distance, table and pad attenuation, backscatter (about 1.3–1.4), the tissue-to-air f-factor (about 1.06), and how much the beam angles overlap.

NCRP Report 168 suggests substantial radiation dose levels of 3 Gy peak skin dose, 5 Gy reference air kerma, 500 Gy·cm² kerma-area product, or 60 minutes of fluoroscopy time.

When a substantial radiation dose level is exceeded, the dose is documented, the patient is told to watch for skin changes, and follow-up is arranged (SIR guidance suggests contact 2–4 weeks after the procedure).

The Joint Commission treats prolonged fluoroscopy with a cumulative peak skin dose of 15 Gy or more to a single field as a sentinel event, requiring a comprehensive systematic analysis and action plan within 45 business days.

Last updated: October 2026

Radiobiology of Skin Injury in Interventional Fluoroscopy

Complex fluoroscopically guided interventional (FGI) procedures—including chronic total occlusion (CTO) coronary recanalization, transjugular intrahepatic portosystemic shunts (TIPS), endovascular aortic repairs (EVAR), and neurovascular embolizations—often involve prolonged beam-on times and high-dose digital subtraction angiography (DSA). Under prolonged static gantry angulation or high dose rates, these procedures can deliver massive localized radiation doses to patient skin, inducing radiation dermatitis. Unlike stochastic oncogenic risks, radiation skin injury is a deterministic tissue reaction governed by a threshold dose below which injury does not occur and above which severity scales directly with dose.

Pathogenesis of Cutaneous Radiation Reactions

The critical target of acute cutaneous radiation damage is the clonogenic stem cell pool in the basal layer of the epidermis (located ≈ 0.1 mm \approx 0.1\text{ mm} ≈ 0.1 mm beneath the skin surface) and endothelial cells lining the superficial dermal microvascular plexus. Ionizing radiation causes double-strand DNA breaks and reactive oxygen species generation, triggering apoptosis in dividing basal keratinocytes and microvascular endothelial cells.

Endothelial damage induces microvascular thrombosis, acute tissue ischemia, and an inflammatory cytokine cascade (TNF- α \alpha α , IL-1, IL-6). Because normal epidermal cell renewal requires 14 to 28 days for basal keratinocytes to divide and migrate to the stratum corneum, clinical signs of cell depletion manifest along predictable latency windows.

Dose Thresholds, Latency Periods, and Clinical Progression

NCRP Report 168 and ICRP Publications 85/120 establish the clinical progression of cutaneous deterministic reactions:

Early Transient Erythema : Threshold ≈ 2.0 Gy \approx 2.0\text{ Gy} ≈ 2.0 Gy ( 2,000 mGy 2{,}000\text{ mGy} 2 , 000 mGy ) . Latency: hours to 24 hours 24\text{ hours} 24 hours . Driven by acute microcapillary dilation and histamine release; resolves within 48 hours.

Epilation (Alopecia) :

Temporary Epilation : Threshold ≈ 3.0 Gy \approx 3.0\text{ Gy} ≈ 3.0 Gy ( 3,000 mGy 3{,}000\text{ mGy} 3 , 000 mGy ) . Latency: 2 to 3 weeks 2\text{ to } 3\text{ weeks} 2 to 3 weeks . Mitotic arrest in hair follicle matrix cells leads to shedding; regrowth occurs within 2 to 6 months.

Permanent Epilation : Threshold ≈ 7.0 Gy \approx 7.0\text{ Gy} ≈ 7.0 Gy ( 7,000 mGy 7{,}000\text{ mGy} 7 , 000 mGy ) . Latency: ≈ 3 weeks \approx 3\text{ weeks} ≈ 3 weeks . Irreversible follicular stem cell destruction causes permanent alopecia.

Main (Sustained) Erythema : Threshold ≈ 6.0 Gy \approx 6.0\text{ Gy} ≈ 6.0 Gy ( 6,000 mGy 6{,}000\text{ mGy} 6 , 000 mGy ) . Latency: 1 to 3 weeks 1\text{ to } 3\text{ weeks} 1 to 3 weeks . Characterized by painful confluent erythema, edema, and warmth from dermal vasculitis and basal layer depletion.

Dry Desquamation : Threshold ≈ 14 Gy \approx 14\text{ Gy} ≈ 14 Gy . Latency: about 4 weeks 4\text{ weeks} 4 weeks . Basal depletion causes peeling, scaly exfoliation, and itching.

Moist Desquamation : Threshold ≈ 18 Gy \approx 18\text{ Gy} ≈ 18 Gy . Latency: about 4 weeks 4\text{ weeks} 4 weeks . Loss of epidermis exposes weeping dermis, with blistering, pain, and infection risk.

Secondary Ulceration : Threshold ≈ 24 Gy \approx 24\text{ Gy} ≈ 24 Gy . Latency: more than 6 weeks 6\text{ weeks} 6 weeks , when moist desquamation fails to heal.

Ischemic Dermal Necrosis : Threshold ≈ 18 Gy \approx 18\text{ Gy} ≈ 18 Gy . Latency: more than 10 weeks 10\text{ weeks} 10 weeks ; microvascular damage leads to tissue breakdown that may need surgical repair.

These single-exposure thresholds and onset times come from the table in ICRP Publication 85 (after Wagner and colleagues). NCRP Report 168 instead groups expected effects into dose bands: about 2–5 Gy (transient erythema and temporary epilation), 5–10 Gy (erythema and epilation, possibly prolonged), 10–15 Gy (erythema, epilation, possible dry or moist desquamation), and above 15 Gy (moist desquamation, possible ulceration and necrosis; surgery likely).

  • Peak Skin Dose (PSD) Physics & Determination Methodology
  • Discrepancy Between Reference Air Kerma ( K a , r K_{a,r} K a , r ​ ) and Peak Skin Dose

Reference Air Kerma ( K a , r K_{a,r} K a , r ​ ) is NOT equal to Peak Skin Dose (PSD) . K a , r K_{a,r} K a , r ​ is measured at the Interventional Reference Point (IRP, 15 cm 15\text{ cm} 15 cm from isocenter toward the focal spot) in free air without backscatter. Calculating PSD requires accounting for five physical factors:

Inverse-Square Distance : If the table is raised, placing the patient's skin closer to the tube focal spot than d IRP d_{\text{IRP}} d IRP ​ , entrance air kerma increases by ( d IRP / d skin ) 2 (d_{\text{IRP}} / d_{\text{skin}})^2 ( d IRP ​ / d skin ​ ) 2 .

Table and Pad Attenuation : Beams entering through the table and pad undergo attenuation ( T table × T pad ≈ 0.80 – 0.90 T_{\text{table}} \times T_{\text{pad}} \approx 0.80\text{--}0.90 T table ​ × T pad ​ ≈ 0.80 – 0.90 ), reducing skin entrance dose.

Tissue Backscatter Factor ( B B B ) : Compton scattering inside the patient increases entrance surface dose. For diagnostic spectra ( 70 – 120 kVp 70\text{--}120\text{ kVp} 70 – 120 kVp , HVL 3 – 6 mm Al 3\text{--}6\text{ mm Al} 3 – 6 mm Al ), backscatter factor ranges between B ≈ 1.30 and 1.40 B \approx 1.30\text{ and } 1.40 B ≈ 1.30 and 1.40 ( 30 – 40 % 30\text{--}40\% 30 – 40% increase over free air).

Air-to-Tissue f f f -factor : The mass energy-absorption coefficient ratio ( μ en / ρ ) air tissue (\mu_{\text{en}}/\rho)_{\text{air}}^{\text{tissue}} ( μ en ​ / ρ ) air tissue ​ yields 1.06 Gy tissue per Gy air kerma 1.06\text{ Gy tissue per Gy air kerma} 1.06 Gy tissue per Gy air kerma .

Gantry Angulation & Overlap : Rotating the gantry distributes radiation across multiple skin fields ( f overlap < 1.0 f_{\text{overlap}} < 1.0 f overlap ​ < 1.0 ), whereas a fixed projection concentrates all exposure onto a single skin area ( f overlap = 1.0 f_{\text{overlap}} = 1.0 f overlap ​ = 1.0 ).

Mathematical Formulation for Peak Skin Dose

The medical physicist calculates Peak Skin Dose by summing across all gantry projections i i i :

PSD = ∑ i [ K a , r , i ⋅ ( d IRP d skin , i ) 2 ⋅ T table , i ⋅ B i ⋅ ( μ ˉ en ρ ) air tissue ⋅ f overlap , i ] \text{PSD} = \sum_{i} \left[ K_{a,r,i} \cdot \left(\frac{d_{\text{IRP}}}{d_{\text{skin},i}}\right)^2 \cdot T_{\text{table},i} \cdot B_i \cdot \left(\frac{\bar{\mu}_{\text{en}}}{\rho}\right)_{\text{air}}^{\text{tissue}} \cdot f_{\text{overlap},i} \right] PSD = ∑ i ​ [ K a , r , i ​ ⋅ ( d skin , i ​ d IRP ​ ​ ) 2 ⋅ T table , i ​ ⋅ B i ​ ⋅ ( ρ μ ˉ ​ en ​ ​ ) air tissue ​ ⋅ f overlap , i ​ ]

For static single-projection procedures, a practical estimate is PSD ≈ 1.1 to 1.3 × K a , r \text{PSD} \approx 1.1\text{ to } 1.3 \times K_{a,r} PSD ≈ 1.1 to 1.3 × K a , r ​ .

  • Substantial Radiation Dose Level (SRDL) Framework (NCRP Report 168)
  • Institutional SRDL Thresholds

Under NCRP Report No. 168 , a Substantial Radiation Dose Level (SRDL) is a trigger level, set by the institution, above which specific follow-up actions are taken. NCRP 168 suggests:

Peak Skin Dose (PSD) : ≥ 3.0 Gy \ge 3.0\text{ Gy} ≥ 3.0 Gy ( 3,000 mGy 3{,}000\text{ mGy} 3 , 000 mGy )

Reference Air Kerma ( K a , r K_{a,r} K a , r ​ ) : ≥ 5.0 Gy \ge 5.0\text{ Gy} ≥ 5.0 Gy ( 5,000 mGy 5{,}000\text{ mGy} 5 , 000 mGy )

Kerma-Area Product ( P KA P_{\text{KA}} P KA ​ ) : ≥ 500 Gy ⋅ cm 2 \ge 500\text{ Gy}\cdot\text{cm}^2 ≥ 500 Gy ⋅ cm 2 ( 50,000 μ Gy ⋅ m 2 50{,}000\ \mu\text{Gy}\cdot\text{m}^2 50 , 000 μ Gy ⋅ m 2 )

Cumulative Fluoroscopy Time : > 60 minutes > 60\text{ minutes} > 60 minutes (secondary indicator when dosimetric metrics are unavailable).

Clinical Protocol for SRDL Exceedance

A typical institutional pathway, built on NCRP 168 and the Society of Interventional Radiology guidelines, has four steps:

Intra-Procedural Notification : Staff tell the operator when the dose passes notification levels. NCRP 168 suggests a first notification at 3 Gy 3\text{ Gy} 3 Gy reference air kerma (or 2 Gy 2\text{ Gy} 2 Gy peak skin dose, or 300 Gy ⋅ cm 2 300\text{ Gy}\cdot\text{cm}^2 300 Gy ⋅ cm 2 for a 100 cm 2 100\text{ cm}^2 100 cm 2 field) and further notifications every 1 Gy 1\text{ Gy} 1 Gy (or 0.5 Gy 0.5\text{ Gy} 0.5 Gy peak skin dose, or 100 Gy ⋅ cm 2 100\text{ Gy}\cdot\text{cm}^2 100 Gy ⋅ cm 2 ), so the operator can change beam angles, collimate, or stage the procedure.

Medical Record Documentation : Reference air kerma and kerma-area product (or fluoroscopy time and image count if the equipment cannot report them) are recorded in a retrievable format, as The Joint Commission requires.

Medical Physicist Dose Estimate : For cases above the SRDL, a medical physicist estimates the peak skin dose from the DICOM Radiation Dose Structured Report and procedure geometry, promptly when the estimate could approach the sentinel event level.

Clinical Follow-up : The patient and referring physician are told what skin changes to watch for, and follow-up is arranged; SIR guidance suggests contacting the patient about 2 to 4 weeks after the procedure, with longer follow-up for higher doses.

  • The Joint Commission (TJC) Imaging Standards & Sentinel Events
  • TJC Fluoroscopy Requirements

Since 2019 the Joint Commission's fluoroscopy elements of performance have required accredited organizations to:

Have a diagnostic medical physicist perform an annual performance evaluation of fluoroscopic equipment, including beam alignment and collimation, kVp accuracy, HVL, high- and low-contrast resolution, maximum exposure rate in all modes, and the accuracy of displayed air kerma rate and cumulative air kerma.

Document cumulative air kerma or kerma-area product in a retrievable format (fluoroscopy time and number of images if the equipment cannot report them).

Verify that staff who use fluoroscopy receive ongoing (annual) radiation safety education .

Review and analyze incidents in which thresholds set by the organization are exceeded.

In 2026 the Joint Commission's Accreditation 360 revision moved hospital imaging safety requirements into National Performance Goal 13, "Protecting Patients and Providers in Imaging," describing the change as a reorganization rather than new requirements.

Sentinel Event Definition ( > 15 Gy >15\text{ Gy} > 15 Gy ) & Root Cause Analysis

The Joint Commission defines a fluoroscopy Sentinel Event as:

Prolonged fluoroscopy with a cumulative peak skin dose of 15 Gy or more to a single field.

The Joint Commission's guidance counts dose accumulated to the same skin field over a period of 6 to 12 months, so earlier procedures matter. A sentinel event requires a comprehensive systematic analysis (root cause analysis) and corrective action plan within 45 business days of the event or of becoming aware of it; reporting the event to the Joint Commission is encouraged but voluntary.

  • Worked Numerical Examples: Clinical Peak Skin Dose Estimation
  • Example 1: Multiview Angioplasty Dose Calculation

A patient undergoes complex coronary angioplasty with cumulative K a , r = 5.8 Gy K_{a,r} = 5.8\text{ Gy} K a , r ​ = 5.8 Gy and KAP = 440 Gy ⋅ cm 2 \text{KAP} = 440\text{ Gy}\cdot\text{cm}^2 KAP = 440 Gy ⋅ cm 2 . Because K a , r ≥ 5.0 Gy K_{a,r} \ge 5.0\text{ Gy} K a , r ​ ≥ 5.0 Gy , the procedure exceeds the SRDL.

The QMP reviews the RDSR: 65 % 65\% 65% of dose ( 3.77 Gy 3.77\text{ Gy} 3.77 Gy ) was delivered in a single LAO cranial projection. The table was positioned at d skin = 63 cm d_{\text{skin}} = 63\text{ cm} d skin ​ = 63 cm ( d IRP = 65 cm d_{\text{IRP}} = 65\text{ cm} d IRP ​ = 65 cm ). Beam traversed the table and pad ( T = 0.88 × 0.95 = 0.836 T = 0.88 \times 0.95 = 0.836 T = 0.88 × 0.95 = 0.836 ). Backscatter factor is B = 1.35 B = 1.35 B = 1.35 , and f = 1.06 Gy/Gy f = 1.06\text{ Gy/Gy} f = 1.06 Gy/Gy .

PSD = 3.77 Gy × ( 65 63 ) 2 × 0.836 × 1.35 × 1.06 = 3.77 × 1.065 × 0.836 × 1.35 × 1.06 = 4.80 Gy \text{PSD} = 3.77\text{ Gy} \times \left(\frac{65}{63}\right)^2 \times 0.836 \times 1.35 \times 1.06 = 3.77 \times 1.065 \times 0.836 \times 1.35 \times 1.06 = 4.80\text{ Gy} PSD = 3.77 Gy × ( 63 65 ​ ) 2 × 0.836 × 1.35 × 1.06 = 3.77 × 1.065 × 0.836 × 1.35 × 1.06 = 4.80 Gy

Because PSD = 4.80 Gy ≥ 3.0 Gy \text{PSD} = 4.80\text{ Gy} \ge 3.0\text{ Gy} PSD = 4.80 Gy ≥ 3.0 Gy , the patient exceeds the PSD SRDL, with possible transient erythema and temporary epilation ( ≈ 3 Gy \approx 3\text{ Gy} ≈ 3 Gy ), but remains below the main erythema threshold ( ≈ 6 Gy \approx 6\text{ Gy} ≈ 6 Gy ) and well below the sentinel event level ( 15 Gy 15\text{ Gy} 15 Gy ). The patient is counseled, and follow-up is arranged at about 3 weeks.

Comparison Table & Clinical Pitfalls

Deterministic Reaction Stage Dose Threshold (Gy) Threshold (mGy) Clinical Latency Characteristic Clinical Presentation

Early Transient Erythema 2.0 Gy 2.0\text{ Gy} 2.0 Gy 2,000 mGy 2{,}000\text{ mGy} 2 , 000 mGy Hours to 24 hr 24\text{ hr} 24 hr Capillary dilation, local histamine release; subsides within 48 hr

Temporary Epilation 3.0 Gy 3.0\text{ Gy} 3.0 Gy 3,000 mGy 3{,}000\text{ mGy} 3 , 000 mGy 2 to 3 weeks 2\text{ to } 3\text{ weeks} 2 to 3 weeks Follicular matrix arrest; hair shedding with complete regrowth in 2–6 mo

Main (Sustained) Erythema 6.0 Gy 6.0\text{ Gy} 6.0 Gy 6,000 mGy 6{,}000\text{ mGy} 6 , 000 mGy 1 to 3 weeks 1\text{ to } 3\text{ weeks} 1 to 3 weeks Painful erythema, edema, and warmth from acute dermal vasculitis

Permanent Epilation 7.0 Gy 7.0\text{ Gy} 7.0 Gy 7,000 mGy 7{,}000\text{ mGy} 7 , 000 mGy ≈ 3 weeks \approx 3\text{ weeks} ≈ 3 weeks Irreversible follicular stem cell destruction; permanent focal baldness

Dry Desquamation 14 Gy 14\text{ Gy} 14 Gy 14,000 mGy 14{,}000\text{ mGy} 14 , 000 mGy ≈ 4 weeks \approx 4\text{ weeks} ≈ 4 weeks Peeling, scaly exfoliation, itching, pigment changes

Moist Desquamation 18 Gy 18\text{ Gy} 18 Gy 18,000 mGy 18{,}000\text{ mGy} 18 , 000 mGy ≈ 4 weeks \approx 4\text{ weeks} ≈ 4 weeks Loss of epidermis exposing weeping dermis, blisters, pain, infection

Ischemic Dermal Necrosis 18 Gy 18\text{ Gy} 18 Gy 18,000 mGy 18{,}000\text{ mGy} 18 , 000 mGy > 10 weeks > 10\text{ weeks} > 10 weeks Microvascular damage and tissue breakdown; may need surgery

Secondary Ulceration 24 Gy 24\text{ Gy} 24 Gy 24,000 mGy 24{,}000\text{ mGy} 24 , 000 mGy > 6 weeks > 6\text{ weeks} > 6 weeks Failure of moist desquamation to heal; chronic ulcer

Clinical Practice Pitfalls

Dismissing Delayed Skin Injuries : Assuming normal skin at discharge rules out injury; main erythema and desquamation take 1 to 5 weeks to manifest.

Static C-arm Angulation : Keeping the gantry in a fixed angle concentrates all incident air kerma on a single skin patch, multiplying injury risk.

Ignoring Prior Interventions : Overlooking procedures to the same skin field in the previous 6 to 12 months risks crossing the 15 Gy sentinel event level during repeat interventions.

Neglecting Table Height Effects : Elevating the table brings patient skin closer to the tube focal spot, dramatically escalating skin dose via inverse-square effects.